[免疫抑制,桃体切除和缓解在高风险的IgA腎病症]
Z S Kochoyan1, A Z Lieva1, T O Galkovskaya1
1Pavlov First Saint Petersburg State Medical University.
Terapevticheskii arkhiv
|August 6, 2024
概括
将桃体切除术添加到免疫抑制疗法中,可显著改善高风险IgA脏病 (IgAN) 患者的缓解率. 与单独治疗相比,这种组合治疗提供了实现完全或整体缓解的更大机会.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- IgA脏病 (IgAN) 是一种常见的初级血球炎.
- 高风险的Igan患者面临疾病进展的显著风险.
- 高风险IgAN的有效治疗策略至关重要.
研究的目的:
- 为了评估免疫抑制疗法 (IST) 与桃体切除术 (TE) 结合的疗法与单独的IST在高风险Igan患者中的疗效.
- 评估TE对实现完全 (CR) 和整体缓解 (OR) 的影响.
主要方法:
- 对213名高风险Igan患者进行了回顾性研究.
- 接受IST (n=141) 和接受IST+TE (n=72) 的患者之间的比较.
- 在26个月的中位随访期内分析缓解率 (CR,部分缓解 (PR) 和OR).
主要成果:
- 与IST组 (65.2%) (p=0.002) 相比,IST+TE组显示早期CR或OR (86.1%) 的发病率更高.
- IST+TE显著增加了早期CR或OR的可能性 (HR 1.714-3.410).
- 在随访时,IST+TE与CR或OR的可能性增加了3至4倍 (HR 2.575-4.768).
结论:
- 桃体切除术 (TE) 可能增强高风险IgA脏病 (IgAN) 的缓解诱导.
- IST和TE的组合似乎是一个有前途的治疗方法,用于改善高风险IGAN的结果.
- 需要进一步的前性研究来证实这些发现.
相关概念视频
Tonsillitis II: Management
105
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
105
Chronic Pharyngitis
1.5K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.5K
Tonsillitis I: Introduction
217
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Etiology
Three primary contributing factors have been identified.
217
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413


